2DG DRDO: Rajnath Singh releases 2-DG(2-deoxy-D-glucose) anti-Covid drug developed by DRDO | India News

2DG DRDO: Rajnath Singh releases 2-DG(2-deoxy-D-glucose) anti-Covid drug developed by DRDO | India News
NEW DELHI: Defence minister Rajnath Singh released the first first batch of the 2-deoxy-D-glucose (2-DG) drug developed by the Defence Research and Development Organisation (DRDO) for treatment of Covid-19 on Monday.
The anti-COVID therapeutic application of the drug has been developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a leading laboratory of the DRDO, in collaboration with Dr Reddy’s Laboratories (DRL) in Hyderabad.
The drug comes in a powder form in a sachet and is taken orally by dissolving it in water, the ministry said.
In efficacy trends, it said, patients treated with 2-DG showed a faster symptomatic cure than the standard of care (SoC) on various endpoints.
(With inputs from PTI)

Be the first to comment

Leave a Reply

Your email address will not be published.


*